You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company has taken an exclusive license to the Casɸ proteins and is working to characterize their capabilities to determine how they can best be used.
Exome sequencing had lower sensitivity and specificity for finding inborn errors of metabolism than conventional screening, but appeared to refine mass spec-based results.
In Science this week: chromatin accessibility of microglia during fetal development, and more.
In Science this week: model to predict coral bleaching, and more.
The CasΦ nuclease, which was first discovered in February, is one of the most compact CRISPR proteins ever found, and is active in both human and plant cells.
In Science this week: Fiber-seq method to examine regulatory architecture, mutations in SOST associated with osteoporosis drug-linked cardiovascular events, and more.
In Genome Biology this week: computational approach to determine phylogenetic relationships from single-cell data, metagenomic classification pipeline, and more.
Nature News reports that academic labs switching to run SARS-CoV-2 diagnostic tests have run into a number of hurdles.
Women with breast cancer from Peru, Mexico, or Colombia who had greater Indigenous American ancestry were more likely to have HER2-positive tumors.
Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.
Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.
Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.
A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.
In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.